Initial hemocompatibility studies of titanium and zirconium alloys: prekallikrein activation, fibrinogen adsorption, and their correlation with surface electrochemical properties.

Two novel metal alloys, Ti-13Nb-13Zr and Zr-2.5Nb, have been engineered for applications in orthopedic implants because of their favorable mechanical properties, corrosion resistance, and compatibility with bone and tissue. These alloys also have the ability to form a hard, abrasion-resistant, ceramic surface layer upon oxidative heat treatment (diffusion hardening, DH). Previous studies have indicated that these and other ceramics cause limited hemolysis and exhibit remarkable structural integrity after extended exposure to physiological environments. Such observations suggest that DH Ti-13Nb-13Zr and ZrO2/Zr-2.5Nb could be used successfully as components in blood-contacting devices. Materials intended for such applications must possess properties that do not elicit adverse physiological responses, such as the initiation of the coagulation cascade or thrombus formation. In the present study measurements of prekallikrein activation, fibrinogen adsorption from diluted human plasma, and the strength of fibrinogen attachment as judged by residence-time experiments were performed to evaluate the potential hemocompatibility of these materials. The results of the prekallikrein activation and fibrinogen-retention studies correlated well with two electrochemical properties of the alloys, the open circuit potential and reciprocal polarization resistance. The results indicate that both the original and treated Ti and Zr alloys activate prekallikrein and adsorb as well as retain fibrinogen in amounts similar to other materials used as components of blood-contacting devices. On the basis of these studies, these alloys appear to be promising candidates for cardiovascular applications and merit further investigation.

Wear-resistant, hemocompatible Ti-Nb-Zr and Zr-Nb alloys to improve blood pump design and performance.

Over the past several years, we have developed novel titanium-niobium-zirconium (Ti-Nb-Zr) alloys to address the long-term performance needs of orthopedic implants. The unique properties of these alloys also render them promising candidates for blood pumps. These properties include excellent biocompatibility in combination with high strength and toughness, and low elastic modulus (low stiffness). Additionally, these metal alloys are readily hot or cold worked into complex shapes including wire, foil, tubing and bar. They are readily machined and polished, and they can be surface oxidized to form a hard, wear-resistant, low-friction ceramic surface layer. In this diffusion-hardened condition, oxygen also hardens the underlying metal to optimize the bone between the ceramic oxide surface and the tough metal substrate. Unlike metal surfaces, oxidative wear, which can alter surface energy, friction, and hemocompatibility, does not occur. Consequently, the combined benefits of a stable, wear-resistant, low-friction ceramic surface layer with the toughness, strength, formability, and thermal conductivity of metal may provide improvements in the design and performance of blood pumps and peripheral graft and percutaneous (power) components of the pump.